CRWV insider sale notice: Founders' shares to be sold Oct 1, 2025

Rhea-AI Filing Summary

Form 144 notice for CoreWeave, Inc. (CRWV): The filer notified intent to sell 14,615 shares of common stock, with an aggregate market value of $2,000,062.75, from a total of 370,470,348 shares outstanding. The proposed sale is listed for 10/01/2025 on NASDAQ. The shares were acquired as Founders Shares from the issuer on 12/27/2023, with the acquisition and payment dated the same day. Recent reported sales by related parties or accounts over the prior three months include multiple 10b5-1 plan transactions totaling material quantities (examples: 281,250 shares on 09/17/2025 for $33,379,846.88; 281,250 on 09/03/2025 for $25,487,803.13) and individual sales by Brian Venturo (e.g., 65,593 shares on 09/30/2025 for $9,146,287.92). The filer attests to no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small insider sale notice relative to outstanding shares; multiple larger 10b5-1 transactions occurred recently, indicating planned liquidity by insiders.

The Form 144 reports a proposed sale of 14,615 common shares valued at $2.0 million, representing a very small fraction of the 370,470,348 shares outstanding. The securities were acquired as founders' shares on 12/27/2023. The filing also discloses several significant 10b5-1 plan sales and an individual sale by Brian Venturo in September 2025, with proceeds in the millions per transaction. For investors, the proposed sale itself is immaterial on a percentage basis, but the clustered 10b5-1 sales show ongoing insider liquidity events that could be relevant when assessing insider disposition patterns.

Corporate Governance Expert

TL;DR: Filing is a routine Rule 144 notice; disclosure of 10b5-1 plan sales is consistent with orderly insider selling practices.

The notice follows Rule 144 disclosure requirements and includes the required representation about lack of undisclosed material information. The securities to be sold were labeled as founders' shares and purchased from the issuer. Multiple entries identify 10b5-1 sales by related entities and trusts, which suggests preplanned dispositions rather than opportunistic trades. This is a standard governance disclosure; no compliance issues are evident from the provided text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14615	2000062.75	370470348	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			14615	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRIAN VENTURO 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/30/2025	65593	9146287.92
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/17/2025	281250	33379846.88
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/03/2025	281250	25487803.13
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	19410	1808187.08
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	19410	1808187.08
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	281250	24777421.88
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)